JPRN-UMIN000000940
Completed
Phase 3
Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease - Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease
Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease (RAISE) Study Group0 sites392 target enrollmentJanuary 27, 2008
ConditionsKawasaki disease
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Kawasaki disease
- Sponsor
- Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease (RAISE) Study Group
- Enrollment
- 392
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients without informed consent to participate in this study. 2\. Patients with past histories of Kawasaki disease (recurrent cases). 3\. Patients diagnosed on the ninth day of illness or later (the first illness day is defined as the day when the patient develops a fever). 4\. Kawasaki disease patients with coronary lesions before starting treatment. 5\. Kawasaki disease patients being afebrile before starting treatment. 6\. Patients having received steroids (oral, intravenous, intramuscular, or subcutaneous) within a month. 7\. Patients having received intravenous immune gamma\-globulin infusion. 8\. Patients with the following severe diseases: immunodeficiency, chromosomal anomalies, congenital heart diseases, metabolic diseases, nephritis, collagen diseases, etc. 9\. Patients with the following active bacterial infections: sepsis, septic meningitis, peritonitis, bacterial pneumonia, etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Trial to study the effect of Curvic® in vaccinated population for COVID-19Vaccinated for COVID-19Infections and InfestationsCOVID-19 (SARS-CoV-2 infection)ISRCTN26285740Shreepad Shree Vallabh SSV Phytopharmaceuticals50
Completed
Phase 1
Seasonal influenza vaccine study to determine the effect of an adjuvanted 2012 influenza vaccine in adultsPrevention of influenza infectionInfection - Other infectious diseasesPublic Health - Other public healthACTRN12612000709842Vaxine Pty Ltd200
Not yet recruiting
Phase 3
Trial for Use of a drug called Intravenous Immunoglobulin in young patients with dilated heart conditioHealth Condition 1: null- Young Patients (less than 25 yrs of age) with history of dilated cardiomyopathy with onset less than 6 months beforeCTRI/2018/01/011421All india institute of medical sciences New Delhi
Completed
Phase 3
A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalitiesKawasaki diseaseJPRN-UMIN000009524agoya University Graduate School of Medicine, Department of Pediatrics240
Completed
Phase 3
International neonatal immunotherapy studyInfants with sepsis. Infants being treated with antibiotics are eligible. Infants can be preterm or term.Reproductive Health and Childbirth - Childbirth and postnatal careInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12606000273583The University of Sydney5,000